Barclays’s American Healthcare REIT AHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32.9M Buy
641,629
+471,016
+276% +$25.8M 0.01% 983
2026
Q2
$8.9M Buy
170,613
+29,321
+21% +$1.44M ﹤0.01% 1536
2026
Q1
$6.66M Sell
141,292
-176,366
-56% -$8.74M ﹤0.01% 1650
2025
Q4
$14.9M Buy
317,658
+7,261
+2% +$337K ﹤0.01% 1415
2025
Q3
$13M Sell
310,397
-47,725
-13% -$1.92M ﹤0.01% 1485
2025
Q2
$13.2M Buy
358,122
+122,200
+52% +$4.06M ﹤0.01% 1379
2025
Q1
$7.15M Sell
235,922
-89,332
-27% -$2.58M ﹤0.01% 1642
2024
Q4
$9.24M Buy
325,254
+146,938
+82% +$3.95M ﹤0.01% 1636
2024
Q3
$4.65M Buy
178,316
+102,588
+135% +$2M ﹤0.01% 2157
2024
Q2
$1.11M Buy
+75,728
New +$1.07M ﹤0.01% 2538

Other funds holding AHR

Barclays's AHR Position: Q3 2026 in Review

Barclays increased its American Healthcare REIT (AHR) stake by 276% in Q3 2026, buying an estimated $25.8M and bringing the position to 641,629 shares worth $32.9M. The position accounts for 0.01% of the portfolio, ranked #983.

Barclays first reported a position in AHR in Q2 2024 and has held it in 10 quarters since. 322 funds tracked by Wall St. Rank hold AHR as of Q3 2026.

  • Barclays held 641,629 shares of American Healthcare REIT worth $32.9M as of Q3 2026.
  • Barclays bought 471,016 American Healthcare REIT shares in Q3 2026, an estimated $25.8M.
  • American Healthcare REIT made up 0.01% of Barclays's portfolio in Q3 2026, its #983 holding.
  • Barclays first reported a position in American Healthcare REIT in Q2 2024 and has held it in 10 quarters since.
  • 322 funds tracked by Wall St. Rank held American Healthcare REIT as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.